Tyrosine Kinase Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

Tyrosine Kinase Stocks Recent News

Date Stock Title
May 3 BPMC Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
May 3 BPMC Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 3 BBIO BridgeBio Pharma First Quarter 2024 Earnings: Beats Expectations
May 3 BBIO BridgeBio Oncology Therapeutics launches with $200m funding
May 3 BPMC Blueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ...
May 3 BPMC Q1 2024 Blueprint Medicines Corp Earnings Call
May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
May 2 BPMC Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript
May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
May 2 BPMC Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation
May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 2 ALLR Allarity rallies on conclusion of mid-stage trial for its ovarian cancer treatment after showing clinical benefit
May 2 BPMC Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...
May 2 BPMC Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
May 2 ALLR Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
May 2 BBIO BridgeBio Pharma GAAP EPS of -$0.20 beats by $0.31, revenue of $211.12M beats by $127.34M
May 2 BBIO BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
May 2 BPMC Blueprint Medicines  GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M
May 2 BPMC Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
May 2 BBIO BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
Tyrosine Kinase

Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

Browse All Tags